菌性多发性硬化症:治疗方法的挑战
Jude ElSaygh1, Nicole Kandinova1, Anas Zaher1
1Internal Medicine, NewYork Presbyterian - Brooklyn Methodist Hospital, New York, USA.
Cureus
|August 14, 2023
概括
瘤性多发性硬化症是一种罕见的疾病,由于模仿脑瘤的大型病变,它带来了诊断挑战. 这一案例突显了尽管治疗,但异常进展,强调了独特的诊断和管理考虑因素.
科学领域:
- 神经免疫学 神经免疫学
- 神经学 神经学
- 放射学 放射学是一门学科.
背景情况:
- 瘤性多发性硬化症 (TOMS) 是多发性硬化症 (MS) 的一种罕见变体.
- 姆斯病变通常很大 (>2厘米) 和单独,经常呈现出显著的血管性.
- 这些特征经常导致误诊为原发性内恶性瘤.
研究的目的:
- 在一个年轻的女性中呈现一种瘤性多发性硬化症病例.
- 讨论TOMS的诊断考虑和管理.
- 为了突出非典型的疾病进展和治疗反应.
主要方法:
- 一个25岁的女性视野缺陷的案例报告.
- 大脑磁共振成像 (MRI) 揭示了带有的大型损伤.
- 瘤性多发性硬化症的诊断工作.
主要成果:
- 瘤性多发性硬化症的诊断得到证实.
- 由于感染问题,患者接受了静脉注射免疫球蛋白.
- 在重复的MRI中观察到症状的矛盾进展和病变扩张.
结论:
- 瘤性多发性硬化症需要仔细的诊断评估,以区别于瘤.
- 管理策略,包括选择免疫抑制药物,至关重要.
- 非典型的表现和治疗反应强调了TOMS的复杂性.
相关概念视频
01:27Tumor Immunotherapy
557
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
557
01:20Myasthenia Gravis: Overview and Treatment
1.6K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.6K
02:49Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K